TradingView
RocketTickers
Aug 30, 2021 4:36 PM
Poseida Therapeutics Announces FDA Clearance of Investigational
Long
NASDAQ:PSTX
60
Poseida Therapeutics, Inc.
NASDAQ
Description
⋅
Aug 30, 2021 4:36 PM
PSTX: Poseida Therapeutics, Inc.
2021-08-30 08:00:00
Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-BCMA-ALLO1, an Allogeneic CAR-T Candidate for Relapsed/Refractory Multiple Myeloma
Beyond Technical Analysis
More